Rituximab plus ifosfamide, carboplatin and etoposide for T-Cell/histiocyte-rich B-cell lymphoma arising in nodular lymphocyte-predominant Hodgkin's lymphoma

Case Reports in Oncology

Volumn 5, Issue 2, 2012, Pages 413-419

  Park, Hyung Chul ^a   Jung, Sung Hoon ^a   Ahn, Jae Sook ^a   Kim, Mi Young ^a   Yang, Deok Hwan ^a   Kim, Yeo Kyeoung ^a   Kim, Hyeoung Joon ^a   Lee, Je Jung ^a  

^a Chonnam National University   (South Korea)

Author keywords

Chemotherapy; Nodular lymphocyte predominant Hodgkin's lymphoma; T cell histiocyte rich B cell lymphoma; Transformation

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PREDNISOLONE; RITUXIMAB; VINBLASTINE; VINCRISTINE;

ADULT; ANGINA PECTORIS; ARTICLE; B CELL LYMPHOMA; BLAST CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CARDIOTOXICITY; CASE REPORT; CELL ISOLATION; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; HISTIOCYTE; HISTIOCYTE RICH B CELL LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHOCYTE; LYMPHOGRAPHY; MALE; MALIGNANT TRANSFORMATION; MULTIPLE CYCLE TREATMENT; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; T CELL LYMPHOMA; TREATMENT RESPONSE;

EID: 84866874620     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000341562     Document Type: Article

References (15)

1. Poppema S: Lymphocyte-predominance Hodgkin's disease. Semin Diagn Pathol 1992;9:257-264.
2. Chan WC: Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: Immunophenotypic and molecular studies. Semin Hematol 1999;36:242-252.
3. Lee AI, LaCasce AS: Nodular lymphocyte predominant Hodgkin lymphoma. Oncologist 2009;14:739-751.
4. Rudiger T, Gascoyne RD, Jaffe ES, et al: Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol 2002;13(suppl 1):44-51.
5. Bennett MH, MacLennan KA, Vaughan Hudson G, Vaughan Hudson B: Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: A 20-year experience. British National Lymphoma Investigation. Ann Oncol 1991;2(suppl 2):83-92.
6. Achten R, Verhoef G, De Wolf-Peeters C: The importance of follow-up biopsies of clinically suspicious lymphadenopathy in nodular lymphocyte predominant Hodgkin's lymphoma. Haematologica 2003;88:1431-1432.
7. Al-Mansour M, Connors JM, Gascoyne RD, Skinnider B, Savage KJ: Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma. J Clin Oncol 2010;28:793-799.
8. Boudova L, Torlakovic E, Delabie J, et al: Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 2003;102:3753-3758.
9. Abramson JS: T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management. Oncologist 2006;11:384-392.
10. Fraga M, Sanchez-Verde L, Forteza J, Garcia-Rivero A, Piris MA: T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: Differential diagnosis from Hodgkin's lymphoma. Histopathology 2002;41:216-229.
11. Harris NL, Jaffe ES, Diebold J, et al: The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November, 1997. Hematol J 2000;1:53-66.
12. Sundeen JT, Cossman J, Jaffe ES: Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent 'large cell lymphoma'. Histological progression or composite malignancy? Am J Surg Pathol 1988;12:599-606.
13. Huang JZ, Weisenburger DD, Vose JM, et al: Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: A report of 21 cases from the Nebraska Lymphoma Study Group. Leuk Lymphoma 2004;45:1551-1557.
14. Torlakovic E, Tierens A, Dang HD, Delabie J: The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol 2001;159:1807-1814.
15. Elbl L, Vasova I, Kral Z, Navratil M, Smardova L, Vorlicek J: Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin's disease with ABVD regimen. Neoplasma 2006;53:62-66.